Using tumour vaccination protocols with no interleukin-2 or α-interferon, Repmann et al (2003) and Jocham et al (2004) were the first investigators reporting positive adjuvant treatment results in locally advanced renal cell carcinoma. This evidence concerns the gene IL2 and neoplasm.